Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2010.01.007PMID 20097195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen Receptor Alpha Represses Transcription of Early Target Genes via p300 and CtBP1

  2009cited by this paper
• Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.

  2009cited by this paper
• CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53

  2009cited by this paper
• Regulation of Autophagy by the p300 Acetyltransferase*

  2009cited by this paper
• Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.

  2008cited by this paper
• The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome

  2008cited by this paper
• Proteasome inhibitors: antitumor effects and beyond

  2007cited by this paper
• Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis

  2007cited by this paper
• Distinct embryonic expression and localization of CBP and p300 histone acetyltransferases at the mouse alphaA-crystallin locus in lens.

  2007cited by this paper
• Ubiquitin-Dependent Distribution of the Transcriptional Coactivator p300 in Cytoplasmic Inclusion Bodies

  2007cited by this paper
• Expression of HDAC1 and CBP/p300 in human colorectal carcinomas

  2007cited by this paper
• Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

  2006cited by this paper
• p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.

  2006cited by this paper
• Disease-related Prion Protein Forms Aggresomes in Neuronal Cells Leading to Caspase Activation and Apoptosis*

  2005cited by this paper
• Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy

  2005cited by this paper
• The ubiquitin-proteasome pathway and its role in cancer.

  2005cited by this paper
• B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation

  2005cited by this paper
• Role of Akt/protein kinase B in the activity of transcriptional coactivator p300

  2004cited by this paper
• The proteasome: a suitable antineoplastic target

  2004cited by this paper
• Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.

  2004cited by this paper
• Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective*

  2004cited by this paper
• Concomitant Increase of Histone Acetyltransferase Activity and Degradation of p300 during Retinoic Acid-induced Differentiation of F9 Cells*

  2003cited by this paper
• Animal Model Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

  2003cited by this paper
• Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator

  2003cited by this paper
• pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-α in breast cancer

  2003cited by this paper
• p300 in prostate cancer proliferation and progression.

  2003cited by this paper
• Hassles with Taking Out the Garbage: Aggravating Aggresomes

  2002cited by this paper
• Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).

  2001cited by this paper
• p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

  2001cited by this paper
• Proteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription

  2000cited by this paper
• Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.

  2000cited by this paper
• Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer

  2000cited by this paper
• Mutations truncating the EP300 acetylase in human cancers

  2000cited by this paper
• The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation

  2000cited by this paper
• The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

  2000cited by this paper
• Aggresomes, inclusion bodies and protein aggregation.

  2000cited by this paper
• Proteasome‐mediated degradation of transcriptional activators correlates with activation domain potency in vivo

  1999cited by this paper
• Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region.

  1999cited by this paper
• The proteasome: a macromolecular assembly designed for controlled proteolysis.

  1999cited by this paper
• Aggresomes: A Cellular Response to Misfolded Proteins

  1998cited by this paper
• Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

  1998cited by this paper
• ER quality control: the cytoplasmic connection.

  1997cited by this paper
• Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)

  1997cited by this paper
• Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines.

  1997cited by this paper
• Recruitment of p300/CBP in p53-dependent signal pathways.

  1997cited by this paper
• The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein

  1996cited by this paper
• p300 gene alterations in colorectal and gastric carcinomas.

  1996cited by this paper
• Association of p300 and CBP with simian virus 40 large T antigen

  1996cited by this paper
• Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma

  1995cited by this paper
• Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

  1994cited by this paper
• Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

  1992cited by this paper
• Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification

  1991cited by this paper

• Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer

  2023cites this paper
• Acetylation of Abelson interactor 1 at K416 regulates actin cytoskeleton and smooth muscle contraction

  2021cites this paper
• Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance.

  2020cites this paper
• The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications

  2018cites this paper
• Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer

  2017cites this paper
• Lysine acetyltransferases cyclic adenosine monophosphate response element‐binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation

  2015cites this paper
• Identification and characterization of small-molecule inhibitors of lysine acetyltransferases.

  2015cites this paper
• Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients

  2015cites this paper
• Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma

  2014influential citation
• Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

  2014cites this paper
• Quinoline‐Based p300 Histone Acetyltransferase Inhibitors with Pro‐apoptotic Activity in Human Leukemia U937 Cells

  2014cites this paper
• Breast cancer: mechanisms involved in action of phytoestrogens and epigenetic changes.

  2013cites this paper
• Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents

  2013cites this paper
• Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines

  2013cites this paper
• The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines

  2013influential citation
• Overexpression of Cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma

  2013influential citation
• The Apoptotic Effects of the P 300 Activator on Breast Cancer and Lung Fibroblast Cell Lines

  2013cites this paper
• The effect of CTB on P53 protein acetylation and consequence apoptosis on MCF-7 and MRC-5 cell lines

  2013influential citation
• Chemical Therapeutics Small-Molecule Inhibitors of Acetyltransferase p 300 Identi fi ed by High-Throughput Screening Are Potent Anticancer Agents

  2013cites this paper
• Small-Molecule Inhibitors of Acetyltransferase p300 Identi fi ed by High-Throughput Screening Are Potent Anticancer Agents

  2013cites this paper
• THE APOPTOTIC EFFECTS OF THE P300 ACTIVATOR ON BREAST CANCER AND LUNG FIBROBLAST CELL LINES

  2013cites this paper
• Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas.

  2012cites this paper
• Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma

  2012cites this paper
• High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma

  2012cites this paper
• High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

  2012cites this paper
• Intensive expression of UNC‐51‐like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma

  2011cites this paper
• A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.

  2011cites this paper
• High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma.

  2011cites this paper
• High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis

  2011cites this paper
• Life and death of transcriptional co-activator p300

  2011cites this paper
• Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors

  2011cites this paper
• Histone Modification and Breast Cancer

  2011cites this paper
• High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma

  2011cites this paper
• The Tale of Protein Lysine Acetylation in the Cytoplasm

  2010cites this paper